Diastolic function assessment with left atrial strain in long-term survivors of childhood acute lymphoblastic leukemia.

Cardio-oncology Cardio-oncología Cardiotoxicidad Cardiotoxicity Childhood cancer survivors Diastolic dysfunction Disfunción diastólica Echocardiography Ecocardiografía Left atrial strain Strain de la aurícula izquierda Supervivientes a cáncer infantil

Journal

Revista espanola de cardiologia (English ed.)
ISSN: 1885-5857
Titre abrégé: Rev Esp Cardiol (Engl Ed)
Pays: Spain
ID NLM: 101587954

Informations de publication

Date de publication:
20 May 2023
Historique:
received: 26 01 2023
accepted: 12 05 2023
pubmed: 23 5 2023
medline: 23 5 2023
entrez: 22 5 2023
Statut: aheadofprint

Résumé

Survivors of childhood cancer might be at increased risk of diastolic dysfunction at follow-up due to exposure to cardiotoxic treatment. Although assessment of diastolic function is challenging in this relatively young population, left atrial strain might provide a novel insight in this evaluation. Our aim was to examine diastolic function in a cohort of long-term survivors of childhood acute lymphoblastic leukemia by using left atrial strain and conventional echocardiographic parameters. Long-term survivors who were diagnosed at a single center between 1985 and 2015 and a control group of healthy siblings were recruited. Conventional diastolic function parameters and atrial strain were compared, and the latter was measured during the 3 atrial phases: reservoir (PALS), conduit (LACS) and contraction (PACS). Inverse probability of treatment weighting was used to account for differences between the groups. We analyzed 90 survivors (age, 24.6±9.7 years, time since diagnosis 18 [11-26] years) and 58 controls. PALS and LACS were significantly reduced compared with the control group: 46.4±11.2 vs 52.1±11.7; P=.003 and 32.5±8.8 vs 38.2±9.3; P=.003, respectively. Conventional diastolic parameters and PACS were similar between the groups. The reductions in PALS and LACS were associated with exposure to cardiotoxic treatment in age- and sex-adjusted analysis (≥ moderate risk, low risk, controls): 45.4±10.5, 49.5±12.9, 52.1±11.7; P Long-term childhood leukemia survivors showed a subtle impairment of diastolic function that was detected with atrial strain but not with conventional measurements. This impairment was more pronounced in those with higher exposure to cardiotoxic treatment.

Sections du résumé

BACKGROUND AND OBJECTIVES OBJECTIVE
Survivors of childhood cancer might be at increased risk of diastolic dysfunction at follow-up due to exposure to cardiotoxic treatment. Although assessment of diastolic function is challenging in this relatively young population, left atrial strain might provide a novel insight in this evaluation. Our aim was to examine diastolic function in a cohort of long-term survivors of childhood acute lymphoblastic leukemia by using left atrial strain and conventional echocardiographic parameters.
METHODS METHODS
Long-term survivors who were diagnosed at a single center between 1985 and 2015 and a control group of healthy siblings were recruited. Conventional diastolic function parameters and atrial strain were compared, and the latter was measured during the 3 atrial phases: reservoir (PALS), conduit (LACS) and contraction (PACS). Inverse probability of treatment weighting was used to account for differences between the groups.
RESULTS RESULTS
We analyzed 90 survivors (age, 24.6±9.7 years, time since diagnosis 18 [11-26] years) and 58 controls. PALS and LACS were significantly reduced compared with the control group: 46.4±11.2 vs 52.1±11.7; P=.003 and 32.5±8.8 vs 38.2±9.3; P=.003, respectively. Conventional diastolic parameters and PACS were similar between the groups. The reductions in PALS and LACS were associated with exposure to cardiotoxic treatment in age- and sex-adjusted analysis (≥ moderate risk, low risk, controls): 45.4±10.5, 49.5±12.9, 52.1±11.7; P
CONCLUSIONS CONCLUSIONS
Long-term childhood leukemia survivors showed a subtle impairment of diastolic function that was detected with atrial strain but not with conventional measurements. This impairment was more pronounced in those with higher exposure to cardiotoxic treatment.

Identifiants

pubmed: 37217136
pii: S1885-5857(23)00138-X
doi: 10.1016/j.rec.2023.05.001
pii:
doi:

Types de publication

Journal Article

Langues

eng spa

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2023 Sociedad Española de Cardiología. Published by Elsevier España, S.L.U. All rights reserved.

Auteurs

Consuelo Fernández-Avilés (C)

Servicio de Cardiología, Hospital Universitario Reina Sofía, Cordoba, Spain; Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC), Cordoba, Spain.

Rafael González-Manzanares (R)

Servicio de Cardiología, Hospital Universitario Reina Sofía, Cordoba, Spain; Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC), Cordoba, Spain. Electronic address: rafaelglezm@gmail.com.

Soledad Ojeda (S)

Servicio de Cardiología, Hospital Universitario Reina Sofía, Cordoba, Spain; Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC), Cordoba, Spain.

José R Molina (JR)

Servicio de Hematología, Hospital Universitario Reina Sofía, Cordoba, Spain.

Gloria Heredia (G)

Servicio de Cardiología, Hospital Universitario Reina Sofía, Cordoba, Spain; Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC), Cordoba, Spain.

Adriana Resúa (A)

Servicio de Cardiología, Hospital Universitario Reina Sofía, Cordoba, Spain; Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC), Cordoba, Spain.

Francisco Hidalgo (F)

Servicio de Cardiología, Hospital Universitario Reina Sofía, Cordoba, Spain; Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC), Cordoba, Spain.

José López-Aguilera (J)

Servicio de Cardiología, Hospital Universitario Reina Sofía, Cordoba, Spain; Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC), Cordoba, Spain.

Dolores Mesa (D)

Servicio de Cardiología, Hospital Universitario Reina Sofía, Cordoba, Spain; Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC), Cordoba, Spain.

Manuel Anguita (M)

Servicio de Cardiología, Hospital Universitario Reina Sofía, Cordoba, Spain; Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC), Cordoba, Spain.

Juan C Castillo (JC)

Servicio de Cardiología, Hospital Universitario Reina Sofía, Cordoba, Spain; Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC), Cordoba, Spain.

Manuel Pan (M)

Servicio de Cardiología, Hospital Universitario Reina Sofía, Cordoba, Spain; Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC), Cordoba, Spain.

Classifications MeSH